Learn More About Power

Why We Started Power

We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.

Bask
Bask GillCEO at Power
Learn More About Trials
How Do Clinical Trials Work?Are Clinical Trials Safe?What Can I Expect During a Clinical Trial?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
1045 Sansome St, Suite 321, San Francisco, CA
hello@withpower.com(415) 900-4227
About UsClinical Trials by ConditionAll Clinical TrialsWork With Us
1
Directories
Conditions
Cities
States
Popular Categories
Depression & Anxiety
Neurology
Psychiatry
Pain
Metabolism
Treatments
Locations
Florida
New Jersey
North Carolina
Texas
Ohio
California
Pennsylvania
Kentucky
New York
Indiana
Psychology Related
Depression
Schizophrenia
Anxiety
PTSD
ADHD
Autism
Bipolar Disorder
Addiction
OCD
Eating Disorder
Treatments
Psilocybin
IVF
Dental Implant
Weight Loss
Smoking
Platelet-Rich Plasma
Testosterone
Saxenda
Melatonin
Entresto
Cities
Saint Louis
Columbus
Portland
Ann Arbor
Aurora
Salt Lake City
Rochester
Birmingham
Detroit
New Haven
Terms of Service·Privacy Policy·Cookies
Cookies & Data Use Policy

At Power, we believe in using data responsibly to help you find the right clinical trials — without compromising your privacy. This page explains how we use cookies and personal data across www.withpower.com.

Before You Create a Profile

When you browse Power's website, you're opting in to our use of cookies. Cookies are used to improve your experience and help us understand how the site is used so that we can make improvements for you in the future. Specifically, we use cookies to:

Personalize Your Experience

We use cookies to customize your visit based on basic information like your general location (determined by your IP address). This allows us to:

  • Show you clinical trials that are geographically relevant to you
  • Tailor search results to match the conditions or keywords you've explored before
  • Pre-fill certain fields or remember your previous searches, so you don't have to repeat them

Save Your Preferences

We remember what you interact with during your visit — for example:

  • The conditions you search for
  • Whether you prefer certain types of studies (e.g., paid trials, trials for a specific age group)
  • Your sorting or filtering preferences when browsing trials

This helps us make your experience more efficient and personalized the next time you visit.

Understand How the Site Is Used

Cookies help us collect anonymous usage data so we can make Power better. We use these insights to:

  • Monitor how users move through the site — for example, which pages get the most traffic and where users tend to exit
  • Track how long visitors stay on each page and whether they find what they’re looking for
  • Identify points of friction or confusion so we can improve usability
  • Test design changes (like different page layouts or buttons) and measure which version performs better
  • Detect and fix bugs or slow-loading pages to maintain site reliability

These analytics are aggregated and do not include personal identifiers. We use tools like Google Analytics to process this data, but we don't use it to target ads or sell your information.

We do not:

  • Sell or share your personal data with advertisers
  • Use your behavior on our site to target you with third-party ads

All cookie use is designed to support your experience on Power — never to track you across the internet or monetize your information.

After You Create a Profile

When you sign up for a Power account, you agree to our Privacy Policy and Terms of Service. Creating a profile allows us to better serve you by tailoring the platform to your specific needs.

Once you create a profile:

  • We may collect additional information about your health and clinical interests to help us match you to the most relevant studies.
  • We continue to use cookies to remember your session, keep you logged in, and personalize your dashboard.
  • You have full control — you can delete your profile at any time, and we'll remove your personal data in accordance with our privacy practices.

We use your data solely to fulfill our mission: helping you find clinical trials that could be a fit — not for advertising or resale.

·Security
Condition
Suggested Conditions
  • Anxiety
  • Depression
  • Alzheimer's Disease
  • Weight Loss
  • Heart Disease
  • Cancer
  • Asthma
Location

    Menopause

    Current Location

    Search
    Menopause
    Show Map
    Map View
    Your Location

    Popular Searches

    By Condition

    Depression Clinical Trials

    Anxiety Clinical Trials

    Schizophrenia Clinical Trials

    ADHD Clinical Trials

    Bipolar Disorder Clinical Trials

    Multiple Sclerosis Clinical Trials

    Autism Clinical Trials

    Treatment Resistant Depression Clinical Trials

    Borderline Personality Disorder Clinical Trials

    Social Anxiety Disorder Clinical Trials

    Parkinson's Disease Clinical Trials

    Alzheimer's Disease Clinical Trials

    By Location

    Clinical Trials in California

    Clinical Trials in Florida

    Clinical Trials in Texas

    Clinical Trials in New York

    Clinical Trials in Ohio

    Clinical Trials in Illinois

    Clinical Trials in Pennsylvania

    Clinical Trials in Michigan

    Clinical Trials in North Carolina

    Clinical Trials in Massachusetts

    Clinical Trials in Missouri

    Clinical Trials in Minnesota

    Other People Viewed

    By Subject

    60 Clinical Paid Trials near Colorado Springs, CO

    21 Bipolar Disorder Trials near Chicago, IL

    Top Endometrial Cancer Clinical Trials

    Top Gastrointestinal Cancer Clinical Trials

    Top Pmdd Clinical Trials

    Top Aging Clinical Trials

    Top Presbyopia Clinical Trials

    Top Achondroplasia Clinical Trials

    Top Psychological Clinical Trials

    Top Leiomyosarcoma Clinical Trials

    Top Osteosarcoma Clinical Trials

    Top Memory Clinical Trials

    By Trial

    Multiple Interventions for Menopause

    NOE-115 for Hot Flashes Due to Menopause

    Salpingectomy with Delayed Oophorectomy for Ovarian Cancer

    Propranolol for Vascular Responses in Menopause

    Fezolinetant for Hot Flashes in Breast Cancer

    Adjuvanted vs Traditional Vaccines for Hepatitis B

    Resistance Training + Creatine for Perimenopause

    Exercise Training for Fat Metabolism in Postmenopausal Women

    Care Coordination with Peer Support for Hepatitis C

    Prosthetic Suspension Systems for Lower Limb Amputation

    Bone Marrow Irradiation + Cyclophosphamide for Acute Myeloid Leukemia

    Ovarian Tissue Transplantation for Female Infertility

    Related Searches

    BTX-A51 for Leukemia

    Neurovascular Responses to Hot Flashes

    Venetoclax + FLAG Chemotherapy for Acute Myeloid Leukemia

    Psilocybin + taVNS for Enhancing Psychedelic Experiences

    PET Imaging for Sickle Cell Crisis

    WiSE CRT System for Heart Failure

    Doxorubicin + Dual Checkpoint Blockade for Soft Tissue Sarcoma

    BG-75098 + Other Agents for Cancer

    Olaparib + Navitoclax for Breast Cancer

    GS-9716 + Anticancer Therapies for Advanced Solid Cancers

    Forging New Paths for Mental Illness

    Tazemetostat for Advanced Cancer with Liver Impairment

    Search Clinical Trials
    Conditions
    Suggestions
    • Anxiety
    • Depression
    • Alzheimer's Disease
    • Weight Loss
    • Heart Disease
    • Cancer
    • Asthma
    Locations
    Suggestions
      Treatment Type
      Suggestions
      • Cognitive Behavioral Therapy
      • Medication Management
      • Group Therapy
      • Psychotherapy
      • Mindfulness-Based Therapy
      • Exposure Therapy

      Trial Phase

      Trial Status

      Paid Participation

      Filters

      0

      Suggestions
      • Cognitive Behavioral Therapy
      • Medication Management
      • Group Therapy
      • Psychotherapy
      • Mindfulness-Based Therapy
      • Exposure Therapy

      Paid Participation

      Trial Status

      Trial Phase

      Clear All
      Why We Started Power

      We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.

      Bask
      Bask GillCEO at Power
      Learn More About Trials
      How Do Clinical Trials Work?Are Clinical Trials Safe?What Can I Expect During a Clinical Trial?

      80 Menopause Trials Near You

      Power is an online platform that helps thousands of Menopause patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.

      Learn More About Power
      No Placebo
      Highly Paid
      Stay on Current Meds
      Pivotal Trials (Near Approval)
      Breakthrough Medication

      Ovarian Tissue Transplantation for Premature Ovarian Failure

      Cleveland, Ohio
      Premature ovarian failure, also known as primary ovarian insufficiency (POI), or premature menopause, affects 1-2% of women under 40. The diagnosis is typically made based on high levels of follicle stimulating hormone (FSH) and absent or irregular menstrual periods. It leads to infertility and menopause-like effects (hot flashes and thin bones) due to low estrogen levels. POI can result from various factors such as genetic conditions, autoimmune diseases, or previous medical treatments like chemotherapy. Treatment of POI usually involves hormone replacement therapy and, if pregnancy is desired, assisted reproductive technologies such as in vitro fertilization (IVF) using an egg donor. However, IVF may not be an option for everyone due to personal, religious, ethical or financial reasons. Recent advances in medicine have identified ovarian tissue transplantation (OTT) as a potential solution. OTT involves transplanting either fresh or frozen ovarian tissue into the pelvic area, where it can begin functioning again. Studies in animals and humans have shown success in restoring hormonal function and even achieving pregnancies in some cases. Initial human trials of ovarian tissue transplants from another individual began with identical twins and have since expanded to include non-identical siblings with compatible tissue matches using immunosuppression. Success rates of OTT have been promising, with multiple live births reported between identical twins. Long-term studies indicate that transplanted tissue can remain functional for up to eight years. Ovarian tissue transplantation offers a promising avenue for women with POI to help restore fertility and hormonal function. Continued research and refinement of tissue techniques are essential to improve outcomes and expand access to this innovative treatment option. This study will enroll 10 participants who will undergo ovarian tissue transplantation donated by a non-identical sister using an immunosuppression protocol at University Hospitals.
      No Placebo Group

      Trial Details

      Trial Status:Not Yet Recruiting
      Trial Phase:Unphased
      Age:21 - 40
      Sex:Female

      Key Eligibility Criteria

      Disqualifiers:Hypertension, Diabetes, Heart Disease, Others
      Must Be Taking:Immunosuppressive Medications

      10 Participants Needed

      Resistance Training for Perimenopause

      Ann Arbor, Michigan
      Women's blood vessel health gets worse after menopause, or "the change of life". Some women exercise less during menopause. Exercise can improve blood vessel health. The investigators want to know if resistance exercise, like lifting weights, can improve blood vessel health in women who are just starting menopause. The investigators also want to know if lifting weights can improve mood, sleep, and quality of life in women going through menopause. The investigators will have two groups of women for this study. One group will lift weights (do resistance exercise) twice per week, and the other group will get emails with information about menopause. The investigators will measure blood vessel health, sleep, mood, and menopause symptoms at the start and the end of this study and compare women who did and did not exercise.
      No Placebo Group

      Trial Details

      Trial Status:Recruiting
      Trial Phase:Unphased
      Age:40 - 60
      Sex:Female

      Key Eligibility Criteria

      Disqualifiers:Pregnancy, Smoking, Surgical Menopause, Others
      Must Not Be Taking:Hormone Therapy, Steroids, Diabetes Meds, Others

      50 Participants Needed

      Iron Supplementation for Menorrhagia

      West Lafayette, Indiana
      The goal of this clinical trial is to investigate how iron status and heavy bleeding during the menopausal transition affect women's cognitive function and quality of life. The main questions it aims to answer are: * What is the association between iron status, cognitive function, mood, quality of family relationships, and quality of life in perimenopausal women? * How does iron repletion, via supplementation, affect cognitive function, mood, quality of family relationships, and quality of life in perimenopausal women? The investigators will compare the effect of iron supplements to a placebo (gelatin capsule) to see if iron supplements could improve iron status, cognitive function, mood, quality of family relationships, and quality of life of iron-deficient and/or anemic women undergoing the menopausal transition. Each participant will: * Make 2 visits (about 2 hours each - baseline and endline) to the Clinical Research Center at Purdue * Make a very brief visit at midpoint (about 10 minutes) for a checkup * Take a daily study supplement or placebo for 4 months

      Trial Details

      Trial Status:Not Yet Recruiting
      Trial Phase:Unphased
      Sex:Female

      Key Eligibility Criteria

      Disqualifiers:Hematological Disorders, Others
      Must Not Be Taking:Psychoactive Drugs

      240 Participants Needed

      Pollen Extracts for Menopause

      London, Ontario
      The goal of this study is to investigate the effect of pollen extracts on menopausal symptoms in healthy women The main question it aims to answer is: What is the difference in change in severity of menopausal symptoms as assessed by the total Menopause Rating Scale (MRS) score from baseline at Week 36 between Graminex Water Soluble Pollen Extract (WSPE), Lipid Soluble Pollen Extract (LSPE), and Placebo? Participants will be asked to complete the MRS assessment tool to rate their menopausal symptoms while receiving either WSPE, LSPE, or Placebo.

      Trial Details

      Trial Status:Recruiting
      Trial Phase:Phase 2
      Age:45 - 65
      Sex:Female

      Key Eligibility Criteria

      Disqualifiers:Cancer, Cardiovascular, Diabetes, Others
      Must Not Be Taking:Cannabinoids, Alcohol

      120 Participants Needed

      Estradiol and Elagolix for Menopause

      University Park, Pennsylvania
      The frequency and severity of heat waves has increased in the last decades. Older adults (over 65 years) have impaired responses to heat stress making them at increased risk for adverse events. Previous heat waves report that women over 65 experience worse health outcomes than any other age group and age matched men. Aging and reproductive hormones, specifically estrogen, independently alter responses to heat stress. However, the combined effects of low estrogen following menopause and aging on the response to heat stress are unknown. In this study, the investigators will identify the role of estrogen in pre and post menopausal women on thermoregulatory responses to heat stress.

      Trial Details

      Trial Status:Recruiting
      Trial Phase:Phase 4
      Age:42 - 64
      Sex:Female

      Key Eligibility Criteria

      Disqualifiers:Chron's, Diverticulitis, Tobacco, Others
      Must Not Be Taking:Hormone Therapy, Hormonal Contraceptives

      24 Participants Needed

      Nitrate Supplementation and Exercise for Menopause

      Charlottesville, Virginia
      Menopause greatly increases cardiovascular disease risk (CVD). Current exercise guidelines are inadequate to ameliorate this risk and higher intensity exercise may be necessary for cardiovascular benefits in postmenopausal females. Oral nitrate supplementation enhances exercise performance and CVD risk profile in several clinical conditions. The investigators recently reported that 3-days of nitrate supplementation in postmenopausal females enhances acute post-exercise vascular function, in an intensity dependent manner. The effects of nitrate supplementation and exercise training over a longer training program remains unexplored. This investigation will examine the impact of exercise training intensity with and without inorganic nitrate supplementation, on CVD and fitness outcomes. Postmenopausal females will be tested for maximal oxygen uptake and lactate threshold before randomization to one of four groups: that inorganic nitrate-rich beetroot juice, or beetroot juice with nitrate extracted; and assigned to one-month of calorie matched high-intensity or moderate-intensity exercise training. Vascular function and fitness will be evaluated before and after training.

      Trial Details

      Trial Status:Recruiting
      Trial Phase:Unphased
      Age:45 - 75
      Sex:Female

      Key Eligibility Criteria

      Disqualifiers:Smoking, Diabetes, Oral Disease, Others
      Must Not Be Taking:Vasoactive Medications, Hormone Therapy

      40 Participants Needed

      Multivitamin + Multi-nutrient Supplement for Menopause

      Chicago, Illinois
      This is a randomized, double-blinded, parallel, placebo-controlled study to investigate the effect of a multivitamin, multi-nutrient supplement on mental and emotional wellbeing in healthy females aged 43 to 55 years, experiencing peri-menopausal and menopausal symptoms

      Trial Details

      Trial Status:Not Yet Recruiting
      Trial Phase:Unphased
      Age:43 - 55
      Sex:Female

      Key Eligibility Criteria

      Disqualifiers:Pregnancy, Alcohol Abuse, Smoking, Others
      Must Not Be Taking:Hypnotics, Psychotropics, Steroids, Others

      80 Participants Needed

      PERI-MIND for Menopause and Dementia Risk

      Chicago, Illinois
      By age 45, women's lifetime risk of dementia is estimated to be 1 in 5. Two-thirds of people currently living with a dementia diagnosis are women, and-women make up the majority of carers for people with dementia. Because women bear a larger burden of the dementia epidemic, they tend to be more fearful about dementia compared to men. Women may be especially fearful during the menopause transition, which can impact cognition. These fears can cause significant psychological distress, functional impairment, and avoidance of help seeking. Interventions that acknowledge women's fears and promote adaptive coping during the menopause transition are needed to combat dementia-related fear and its negative impacts. This project aims to develop, and pilot test a brief personalized, psychosocial intervention for middle-aged perimenopausal individuals with elevated dementia risk. The investigators will assess the intervention's acceptability and feasibility for use in this population. The project will be completed in three stages. First, the investigators will conduct focus groups to better understand individual fears about dementia, informational and decisional needs, and strategies to promote adaptive coping as they transition through menopause (case-only, single time point). Second, the investigators will develop an intervention to meet the specific needs identified by the focus groups. Intervention components will address multiple areas of women's health in midlife, including aspects of physical and psychological health, as well as functional health outcomes that have important and long-lasting life implications. Finally, the investigators will conduct pilot testing to assess the acceptability and feasibility of the intervention (cohort, 3-week testing period). This project will deliver a novel psychosocial intervention that can provide middle-aged perimenopausal women with the information and practical skills that can help them manage their dementia-related fears and encourage adaptive coping behaviors. Outputs from the project will serve as preliminary data for a fully powered randomized controlled trial.
      No Placebo Group

      Trial Details

      Trial Status:Recruiting
      Trial Phase:Unphased
      Age:40 - 58
      Sex:Female

      Key Eligibility Criteria

      Disqualifiers:Mild Cognitive Impairment, Alzheimer's, Others

      60 Participants Needed

      Prunes for Osteoporosis

      University Park, Pennsylvania
      Dietary interventions of prune consumption during the transmenopausal period are innovative methods to prevent bone loss. Modern medicine does not intervene to prevent or attenuate this highly vulnerable period of bone loss which, if successfully attenuated, can potentially prevent/delay osteoporosis in women. The transmenopausal period represents an opportunistic window for the study because bone loss is at its greatest at this time, with females losing as much as 6-7% of bone. If this project is successful at attenuating bone loss, it can immediately be disseminated to the public to promote prune consumption to slow down and attenuate perimenopausal bone loss. As such, this project could improve the long-term bone health of females and avoid or delay osteoporosis and improve quality of life. The long-term goal of this study is to test the novel hypothesis that prune consumption for 18 months during the 3-year transmenopausal period prevents the dramatic rate of bone loss in perimenopausal females during a window of heightened physiological vulnerability. At Penn State University, the study will compare the effects of 18 months of daily dietary consumption of 50 g of prunes (5-6) versus a no-prune control group on bone outcomes (bone mineral density, bone geometry), mechanistic factors (bone and inflammatory markers, inflammatory response of ex vivo cultured peripheral blood mononuclear cells, monocytes), and gut microbiome.
      No Placebo Group

      Trial Details

      Trial Status:Not Yet Recruiting
      Trial Phase:Unphased
      Age:44 - 55
      Sex:Female

      Key Eligibility Criteria

      Disqualifiers:Fractures, Thyroid Issues, Renal Impairment, Others
      Must Not Be Taking:Bisphosphonates, Denosumab, Estrogen, Others

      124 Participants Needed

      Duavive for Menopausal Depression

      Hamilton, Ontario
      This study evaluates the impact of conjugated estrogens/ bazedoxifene (CE/ BZA) on the mood (depression and anxiety) in peri- and early menopausal women.
      No Placebo Group

      Trial Details

      Trial Status:Recruiting
      Trial Phase:Phase 1
      Age:45 - 60
      Sex:Female

      Key Eligibility Criteria

      Disqualifiers:Cancer, Thromboembolic Disease, Liver Disease, Others
      Must Not Be Taking:Antidepressants, Psychoactive Medications

      30 Participants Needed

      Hormone Replacement Therapy for Premature Ovarian Failure

      Bethesda, Maryland
      Background: Premature ovarian insufficiency (POI) is a condition in which women under the age of 40 years have absent or irregular menstrual cycles. POI can cause infertility, signs of menopause, osteoporosis, and other symptoms. Hormone replacement therapy (HRT) is a treatment that gives women extra hormones, such as estrogen and progesterone. HRT works well in adult women. Researchers want to find the most effective doses and regimens for adolescents. Objective: To monitor the effects of HRT on adolescents with POI. Eligibility: Female adolescents aged 11 to 19 years diagnosed with POI. Healthy volunteers are also needed. Design: All participants will have clinic visits every 6 months for 2 years. Each visit may last 2 days. Each visit may include: Blood and urine tests. A test of their heart function. A test to measure the stiffness of their blood vessels. Participants will lie flat with a blood pressure cuff on a leg and a meter on the neck while the cuff inflates. A test of their grip strength. Participants will squeeze a handheld device as hard as they can. Two scans to measure bone density. For one, participants will lie on a table while a scanner passes along their body. For the other, participants will sit in a chair and insert their forearm, then their lower leg, into a scanner. A test to measure skin pigmentation. Participants skin will be touched lightly with a device. An optional visual exam of the vagina. Some vaginal fluid may also be collected with a cotton swab/cytobrush. Participants with POI will receive HRT. They will be given estrogen patches and progesterone pills.
      No Placebo Group

      Trial Details

      Trial Status:Recruiting
      Trial Phase:Early Phase 1
      Age:11 - 19
      Sex:Female

      Key Eligibility Criteria

      Disqualifiers:Turner Syndrome, Celiac Disease, Others
      Must Be Taking:Estrogen, Progesterone

      185 Participants Needed

      Exercise Interventions for Perimenopausal Symptoms

      Toronto, Ontario
      Throughout the menopause transition, women experience many symptoms (i.e., hot flashes, night sweats) that can significantly reduce their quality of life. Moreover, their risk of heart disease increases substantially. The years before menopause called "perimenopause" present a critical window of intervention to alleviate menopause symptoms and improve health outcomes. Our team is therefore interested in comparing the potential benefits of different approaches including following the Health Canada guidelines (i.e., accumulating 150 min of moderate-to-vigorous aerobic physical activity weekly); performing high-intensity interval training (HIIT), which involves alternating periods of intense exercise with periods of rest; or stretching in perimenopause. As a first step towards this goal, this study will assess how easy and enjoyable the interventions are to follow over a 6-week period. The information gained from this study will be used to perform a larger study with enough participants to assess the health and quality of life impacts of adopting these different strategies in perimenopause.
      No Placebo Group

      Trial Details

      Trial Status:Recruiting
      Trial Phase:Unphased
      Age:40+
      Sex:Female

      Key Eligibility Criteria

      Disqualifiers:Cardiovascular Disease, Diabetes, Cancer, Others
      Must Not Be Taking:Blood Glucose Medications, Exogenous Hormones

      30 Participants Needed

      PRP Injections for Postmenopausal Syndrome

      Washington D.C., District of Columbia
      Platelet-rich plasma (PRP) is autologous blood which has been centrifuged to separate the supernatant resulting in a solution with high concentration of platelets. Injection of PRP stimulates cell growth and can has been proven safe and effective for uses in orthopedics, dermatology, and gynecology. Despite the relative paucity of data, the use of PRP as a therapy for sexual dysfunction and genitourinary symptoms in the setting of menopause has been patented as the O-Shot and V-Shot. This is a single-blinded randomized control trial to determine if PRP injections into the anterior vaginal wall improve sexual functioning in women diagnosed with the genitourinary syndrome of menopause (GSM) characterized by vaginal dryness/irritation.

      Trial Details

      Trial Status:Active Not Recruiting
      Trial Phase:Unphased
      Sex:Female

      Key Eligibility Criteria

      Disqualifiers:Pelvic Prolapse, Mesh Surgery, Others
      Must Not Be Taking:Anticoagulants, Hormonal Therapy

      30 Participants Needed

      Vegan Diet + Soybeans for Hot Flashes

      Washington, District of Columbia
      This trial tests if a low-fat, vegan diet with soybeans can reduce menopausal hot flashes. Women experiencing these symptoms will follow this diet for a few months. The soybeans might help lessen hot flashes by acting like estrogen. Soy has been studied for its potential to reduce menopausal hot flashes, with varying degrees of success reported in different studies.
      No Placebo Group

      Trial Details

      Trial Status:Active Not Recruiting
      Age:40 - 60
      Sex:Female

      Key Eligibility Criteria

      Disqualifiers:Not Listed

      120 Participants Needed

      Estradiol Products for Menopause

      Baltimore, Maryland
      The purpose is to determine if the two estradiol products can deliver similar amounts of estradiol after single and multiple dosing.
      No Placebo Group

      Trial Details

      Trial Status:Recruiting
      Trial Phase:Early Phase 1
      Age:45 - 65
      Sex:Female

      Key Eligibility Criteria

      Disqualifiers:Smoking, Skin Disorders, Diabetes, Others
      Must Not Be Taking:Estrogens, Antihistamines, Corticosteroids, Others

      12 Participants Needed

      Cognitive Behavioral Therapy for Menopause

      Baltimore, Maryland
      Women are the fastest-growing group of U.S. Veterans. Over half of those using VA care are 45 or older, with more age-related health concerns than civilian women. The VA urgently needs gender-informed strategies to ensure women Veterans receive tailored care that addresses their intersecting mental, physical, and age related health concerns, as well as gender-linked stressors. One prominent example is menopause, a health transition period that, for many women, can be associated with negative physical and mental health concerns that can worsen their functioning and quality of life. This project will: (1) integrate stakeholder feedback to tailor Cognitive Behavioral Therapy for Menopause (CBT-Meno) for women Veterans with menopause concerns; and (2) refine and evaluate tailored CBT-Meno as a treatment to address these intersecting needs in a clinical trial.
      No Placebo Group

      Trial Details

      Trial Status:Not Yet Recruiting
      Trial Phase:Unphased
      Age:45+
      Sex:Female

      Key Eligibility Criteria

      Disqualifiers:Substance Use, Prior CBT-Meno, Others

      48 Participants Needed

      Topical Estrogen for Menopause

      Baltimore, Maryland
      The aim of the present study is to determine if two products can deliver bioequivalent amounts of estrogen (estradiol, estriol, and estrone).
      No Placebo Group

      Trial Details

      Trial Status:Recruiting
      Age:45 - 65
      Sex:Female

      Key Eligibility Criteria

      Disqualifiers:Smoking, Skin Disorders, Diabetes, Others
      Must Not Be Taking:Estrogens, Antihistamines, Corticosteroids, Others

      4 Participants Needed

      Stress Testing for Heart Disease

      Chapel Hill, North Carolina
      Depression is a known risk factor for cardiovascular disease (CVD), and this comorbidity contributes significantly to the morbidity and mortality of women. The menopausal transition or perimenopause is a period of vulnerability for both depression and CVD, making it a key time to study this critical public health issue. This research will preliminarily explore whether disruption in two novel stress pathways 1) the renin-angiotensin-aldosterone system (RAAS) and autonomic nervous system (ANS) and their relationship may underlie the link between these illnesses. Findings will provide important insight into potential mechanisms by which depression during perimenopause may increase risk for CVD in midlife women, which will inform potential risk reduction and treatment strategies that can improve health outcomes in this population.
      No Placebo Group

      Trial Details

      Trial Status:Recruiting
      Trial Phase:Unphased
      Age:44 - 55
      Sex:Female

      Key Eligibility Criteria

      Disqualifiers:Bipolar, Psychotic Disorder, Diabetes, Others
      Must Not Be Taking:Hormonal Agents, Steroids, Antihistamines, Others

      30 Participants Needed

      Gel Dressing 7-0940 for Vulvovaginal Atrophy

      Fayetteville, North Carolina
      This trial is testing a new gel dressing on adult women with specific vulvovaginal skin conditions to see if it is safe and effective over time.
      No Placebo Group

      Trial Details

      Trial Status:Recruiting
      Trial Phase:Unphased
      Sex:Female

      Key Eligibility Criteria

      Disqualifiers:Allergy, Systemic Hormonal Therapy, Others
      Must Not Be Taking:Hormonal Therapy, Corticosteroids

      2000 Participants Needed

      Ashwagandha for Menopause

      Huntsville, Alabama
      The purpose of this study is to evaluate the efficacy of two proprietary ashwagandha extracts on symptoms of menopause and hormone levels, as compared to a placebo.

      Trial Details

      Trial Status:Not Yet Recruiting
      Trial Phase:Unphased
      Age:40 - 55
      Sex:Female

      Key Eligibility Criteria

      Disqualifiers:Pregnancy, Hysterectomy, Liver Disorder, Others
      Must Not Be Taking:Thyroid, Hypertensive, CNS Depressants, Others

      90 Participants Needed

      Why Other Patients Applied

      "I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."

      ZS
      Depression PatientAge: 51

      "I have dealt with voice and vocal fold issues related to paralysis for over 12 years. This problem has negatively impacted virtually every facet of my life. I am an otherwise healthy 48 year old married father of 3 living. My youngest daughter is 12 and has never heard my real voice. I am now having breathing issues related to the paralysis as well as trouble swallowing some liquids. In my research I have seen some recent trials focused on helping people like me."

      AG
      Paralysis PatientAge: 50

      "As a healthy volunteer, I like to participate in as many trials as I'm able to. It's a good way to help research and earn money."

      IZ
      Healthy Volunteer PatientAge: 38

      "I was diagnosed with stage 4 pancreatic cancer three months ago, metastatic to my liver, and I have been receiving and responding well to chemotherapy. My blood work revealed that my tumor markers have gone from 2600 in the beginning to 173 as of now, even with the delay in treatment, they are not going up. CT Scans reveal they have been shrinking as well. However, chemo is seriously deteriorating my body. I have 4 more treatments to go in this 12 treatment cycle. I am just interested in learning about my other options, if any are available to me."

      ID
      Pancreatic Cancer PatientAge: 40

      "My orthopedist recommended a half replacement of my right knee. I have had both hips replaced. Currently have arthritis in knee, shoulder, and thumb. I want to avoid surgery, and I'm open-minded about trying a trial before using surgery as a last resort."

      HZ
      Arthritis PatientAge: 78
      Match to a Menopause Trial

      Silicone Gel vs. Estrogen Cream for Genitourinary Syndrome

      Johns Creek, Georgia
      This trial is testing a new treatment called StrataMGT for women experiencing Genitourinary Syndrome of Menopause (GSM). It aims to see if StrataMGT can improve their quality of life as well as the standard estrogen vaginal cream. Participants will use either StrataMGT or estrogen cream for a period of time and will be monitored regularly.
      No Placebo Group

      Trial Details

      Trial Status:Recruiting
      Trial Phase:Unphased
      Sex:Female

      Key Eligibility Criteria

      Disqualifiers:Estrogen Contraindication, Allergy, Others

      100 Participants Needed

      Stress Response Study for Heart Issues

      Atlanta, Georgia
      Coronary Microvascular Dysfunction (CMD) occurs when there are problems in small blood vessels/arteries in the heart and symptoms of persistent chest pain that impact women. There are an estimated 3 million women in the US with CMD and about 100,000 new cases annually. This research will investigate whether the stress response physiology and autonomic function in response to mental stress are different in women with CMD compared to other groups. The autonomic nervous system (ANS) controls normally involuntary activities, such as heart rate, respiration (breathing), body temperature, blood pressure, and urinary function. This study will also examine how chronic and daily life mental stress affects the heart, blood vessels. Participants from this study will be recruited mainly from Emory Healthcare-associated hospitals, the Emory Heart Disease Center for Prevention, and Emory Healthcare outpatient cardiology clinics. Participants will have physical exams, blood tests, stress tests, exercise tests, surveys, questionnaires, and images taken of their hearts and blood vessels. They will be asked to take home devices to monitor their autonomic function, sleep and to track their mood, stress level, and symptoms for one week. Data and specimens will be saved for future research.
      No Placebo Group

      Trial Details

      Trial Status:Recruiting
      Trial Phase:Unphased
      Age:45 - 100
      Sex:Female

      Key Eligibility Criteria

      Disqualifiers:Hypertension, Diabetes, Hyperlipidemia, Others
      Must Not Be Taking:Cardiac Medications

      150 Participants Needed

      NOE-115 for Hot Flashes Due to Menopause

      Atlanta, Georgia
      The purpose of this study is to determine the safety, tolerability, and preliminary effectiveness of NOE-115 on moderate to severe vasomotor symptoms (hot flashes) due to menopause in women.
      No Placebo Group

      Trial Details

      Trial Status:Active Not Recruiting
      Trial Phase:Phase 2
      Age:45 - 60
      Sex:Female

      Key Eligibility Criteria

      Disqualifiers:Alcohol Use Disorder, Major Depression, Malignant Tumor, Cardiovascular Disease, Others
      Must Not Be Taking:Cannabis, Others

      24 Participants Needed

      Intravaginal Device for Genitourinary Syndrome

      Warren Township, New Jersey
      This pilot study aims to evaluate the safety and effectiveness of the VITA AV Clinical System over a period of up to three months after the last treatment, compared to a sham device. The study focuses on improving vaginal signs and symptoms of Genitourinary Syndrome of Menopause (GSM) in post-menopausal women who experience moderate to severe pain during intercourse (dyspareunia). Long-term follow-up visits will assess the ongoing effectiveness and durability of the treatment, while also collecting safety data.

      Trial Details

      Trial Status:Not Yet Recruiting
      Trial Phase:Unphased
      Sex:Female

      Key Eligibility Criteria

      Disqualifiers:Bleeding Disorders, STDs, Genital Infections, Others
      Must Not Be Taking:Hormone Therapies, Anticoagulants

      60 Participants Needed

      Hyaluronic Acid Therapy for Genitourinary Syndrome

      New York, New York
      This study aims to evaluate whether the administration of vaginal estrogen along with Via, a hyaluronic acid-based vaginal moisturizer, offers superior relief from symptoms of genitourinary syndrome of menopause (GSM) in the urogynecologic patient population, compared to administration of vaginal estrogen alone.
      No Placebo Group

      Trial Details

      Trial Status:Not Yet Recruiting
      Trial Phase:Unphased
      Age:45+
      Sex:Female

      Key Eligibility Criteria

      Disqualifiers:Hormone-sensitive Disease, Others
      Must Not Be Taking:Systemic Hormones, Estrogen Therapies

      196 Participants Needed

      PhytoSERM for Menopause-related Cognitive Impairment

      New York, New York
      This trial tests PhytoSERM, a plant-based supplement that mimics estrogen, in peri- and postmenopausal women. The goal is to see if it helps the brain use glucose better, potentially improving brain function and reducing menopausal symptoms. Participants will take the supplement for several months, with brain scans before and after to measure effects. PhytoSERM is a formulation of genistein, daidzein, and S-equol that may enhance neuron function and estrogenic mechanisms in the brain.

      Trial Details

      Trial Status:Recruiting
      Trial Phase:Phase 2
      Age:45 - 60

      Key Eligibility Criteria

      Disqualifiers:Cognitive Impairment, Breast Cancer, Others
      Must Not Be Taking:Estrogen, Progestin

      100 Participants Needed

      Ovarian Tissue Cryopreservation for Premature Ovarian Failure

      New York, New York
      The study hopes to contribute to the development of technologies of ovarian tissue freezing-thawing and in vitro maturation of immature eggs such that a person at risk for premature ovarian failure might be able to conceive a genetically related child.
      No Placebo Group

      Trial Details

      Trial Status:Recruiting
      Trial Phase:Unphased
      Age:< 45
      Sex:Female

      Key Eligibility Criteria

      Disqualifiers:Menopause, No Surgery Clearance, Others

      300 Participants Needed

      JDS-HF3.0 for Menopause Symptoms

      Harrison, New York
      The goal of this interventional study is to evaluate whether the study product can help improve quality of life and reduce common menopause symptoms-such as joint discomfort, hot flashes and night sweats-in women aged 50-70. The primary research question is whether taking the study product daily for 12 weeks can reduce the severity and frequency of menopause-related symptoms.

      Trial Details

      Trial Status:Recruiting
      Trial Phase:Unphased
      Age:50 - 70
      Sex:Female

      Key Eligibility Criteria

      Disqualifiers:Pregnancy, Heart Disease, Cancer, Others
      Must Not Be Taking:Glucosamine, Chondroitin, Curcumin, Others

      250 Participants Needed

      Phentolamine + Propranolol for Menopause

      Columbia, Missouri
      The investigators aim to assess the interactions between the sympathetic nervous system and the vasculature in women across the menopause transition to better understand why aging women have a higher risk of cardiovascular disease.
      No Placebo Group

      Trial Details

      Trial Status:Recruiting
      Trial Phase:Early Phase 1
      Sex:Female

      Key Eligibility Criteria

      Disqualifiers:Pregnancy, Smoking, Diabetes, Others
      Must Not Be Taking:Prescription Medications

      75 Participants Needed

      Propranolol for Vascular Responses in Menopause

      Columbia, Missouri
      The purpose of this study is to examine hypoxic vasodilation and the role of beta-adrenergic receptors in younger premenopausal, perimenopausal, and older postmenopausal women.

      Trial Details

      Trial Status:Recruiting
      Trial Phase:Early Phase 1
      Sex:Female

      Key Eligibility Criteria

      Disqualifiers:Pregnancy, Smoking, Diabetes, Cancer, Others
      Must Not Be Taking:Prescription Medications

      75 Participants Needed

      123

      Know someone looking for new options?
      Spread the word

      Why We Started Power

      We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.

      Bask
      Bask GillCEO at Power
      Learn More About Trials
      How Do Clinical Trials Work?Are Clinical Trials Safe?What Can I Expect During a Clinical Trial?
      Match to a Trial
      Match to a Trial

      Frequently Asked Questions

      How much do Menopause clinical trials pay?

      Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.

      How do Menopause clinical trials work?

      After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Menopause trials 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length for Menopause is 12 months.

      How do I participate in a study as a "healthy volunteer"?

      Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.

      What does the "phase" of a clinical trial mean?

      The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.

      Do I need to be insured to participate in a Menopause medical study?

      Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.

      What are the newest Menopause clinical trials?

      Most recently, we added Cognitive Behavioral Therapy for Menopause, Fezolinetant for Hot Flashes and Dairy Choline Bioavailability for Postmenopausal Health to the Power online platform.

      How to reverse menopause naturally?

      Natural menopause—the point when ovaries have run out of viable eggs—is biologically irreversible, so no diet, herb, or supplement can make regular periods and fertility reliably return. What you can do is (a) avoid reaching menopause a bit earlier than necessary by not smoking, maintaining a healthy weight, and eating a mostly plant-based, fish-and-legume-rich diet, and (b) lessen hot flashes, sleep trouble, and mood changes with regular exercise, stress-reduction, and cautiously tested aids such as soy foods or short-term black cohosh—checking with your healthcare provider first for interactions or liver concerns. If symptoms are still disruptive, discuss stronger evidence-based options like hormone therapy or newer non-hormonal medications with a clinician.

      What stage of menopause is the hardest?

      For most women, the toughest stretch is late perimenopause and the first year or two after the final period, when estrogen and progesterone swing unpredictably and then fall, driving hot flashes, sleep loss, and mood changes. Individual experience varies—sudden surgical menopause, smoking, stress, or other health issues can shift when symptoms feel worst—so the “hardest stage” is personal. Track your own pattern and discuss lifestyle tweaks or hormone/non-hormone treatments with a menopause-savvy clinician to ease whatever phase is giving you the most trouble.

      Is 46 too early for menopause?

      Menopause at 46 is at the younger end of the normal 45-55-year range, so it isn’t considered “too early” (only menopause before 45 is classed as early and before 40 as premature). Let your clinician know so they can rule out other causes, discuss symptom relief, and check bone and heart health, but in most cases menopause at 46 is simply a normal variation.

      Which hormone replacement therapy is best for weight loss?

      Hormone replacement is only helpful for weight when it corrects a proven deficiency: estrogen/progestin can trim about 1 kg of the usual mid-life gain, levothyroxine stops further gain in true hypothyroidism, and testosterone adds lean tissue but little fat loss in women who are genuinely low. If your hormone levels are normal, none of these therapies will make you slimmer, so treatment choice should focus on relieving deficiency-related symptoms while weight control relies on diet, activity, and (when appropriate) dedicated anti-obesity drugs like semaglutide, which is not HRT.

      What are the signs that you need hormone replacement therapy?

      Think of hormone replacement as a tool for clearly defined situations, not a catch-all fix. For women, doctors consider systemic estrogen (with or without progestin) when hot flashes, night sweats, or vaginal dryness are moderate-to-severe or when menopause occurs early (<40 yrs) and is putting bones at risk; benefit is greatest if therapy starts within 10 years of the last period and there are no major heart-, clot-, or cancer-related contraindications. For men, testosterone is only offered when typical symptoms such as low libido, erectile problems, or loss of muscle strength coexist with TWO separate morning blood tests showing testosterone below the normal range—other causes must first be ruled out. If these criteria fit you, ask your clinician to review the pros, cons, and any needed screening (breast/prostate, heart, clot risk) before deciding on treatment.

      Do you age faster without estrogen?

      Time itself doesn’t speed up, but when estrogen drops after menopause the skin, bones and blood vessels start to thin, weaken and stiffen more quickly, so many women “show” aging sooner than before. Hormone therapy (or other bone- and skin-protective measures like exercise, good diet and sun protection) can slow some of these changes, but because estrogen can also raise the risk of blood clots, stroke or certain cancers, the decision to take it should be made with a doctor after weighing personal risks and goals.

      What happens to a woman's body after menopause?

      Once your periods have been gone for 12 months, estrogen from the ovaries drops to very low levels; in the near term this can cause hot flashes, poor sleep and vaginal dryness, while over the years it speeds up bone loss, shifts cholesterol and belly fat in ways that raise heart-disease risk, and thins skin, hair and pelvic-floor tissues. The good news is that most symptoms can be eased (for example with targeted hormone or non-hormone therapies) and the major risks can be curbed by weight-bearing exercise, calcium/vitamin D, not smoking, heart-healthy eating, and regular check-ups that include bone-density and cholesterol tests—so think in two buckets: manage bothersome symptoms now and adopt long-term habits and screenings to protect bones, heart and pelvic health.

      What burns menopausal belly fat?

      You can’t “spot-burn” belly fat, but studies show menopausal women shrink it fastest when they pair a slightly calorie-reduced, Mediterranean- or high-protein style diet with both progressive strength training (2-3 times a week) and moderate-to-vigorous or interval cardio (about 150 minutes weekly). Quality sleep, stress control and—if appropriate—discussing hormone therapy with your doctor help curb the hormonal shifts that push fat toward the waistline. Think of it as a three-legged stool: smart food choices, muscle-building plus heart-pumping movement, and restorative habits working together to whittle the mid-section.

      What is the monthly injection for menopause?

      The “monthly shot” is a long-acting estrogen called estradiol valerate or estradiol cypionate, sold as Delestrogen or Depo-Estradiol and typically injected into a muscle every 3–4 weeks to ease hot flashes and vaginal dryness. It is reserved for women who cannot use or do not absorb pills, patches, or gels; if you still have a uterus you must also take a progestin to protect the lining, and the usual estrogen safety cautions (blood-clot, stroke, breast-cancer risk) still apply, so the decision should be made with your clinician.

      Why is HRT no longer recommended?

      HRT wasn’t “banned”—practice simply shifted after large studies showed that, in women starting therapy well past menopause, the small benefits were outweighed by higher rates of breast cancer, blood clots, stroke and heart disease. Today, experts still recommend HRT as the most effective treatment for troublesome hot flushes and bone loss when started before age 60 or within 10 years of menopause, but they weigh each woman’s personal risks and stop or adjust it if those risks rise.